Entero Therapeutics, Inc. (ENTO) — Free Cash Flow Generation Index

Latest as of June 2014: 1.00x

Entero Therapeutics, Inc. (ENTO) has a Free Cash Flow Generation Index of 1.00x as of June 2014. Free cash flow of $129.24 represents 1% of operating cash flow ($129.24). Check Entero Therapeutics, Inc. tangible equity quality to evaluate the tangible quality of the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$129.24
USD

Operating Cash Flow

$129.24
USD

Capital Expenditures

$0.00
USD

Entero Therapeutics, Inc. Free Cash Flow Generation Index (2013–2013)

Historical FCF Generation Index trend for Entero Therapeutics, Inc. across 1 annual periods. For the full cash flow conversion analysis, see Entero Therapeutics, Inc. operating cash flow efficiency.

Annual Free Cash Flow Generation for Entero Therapeutics, Inc. (2013–2013)

Year-by-year Free Cash Flow Generation Index for Entero Therapeutics, Inc.. Check ENTO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2013 1.00x $56.55 $56.55 $0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).